Germans Trias i Pujol Research Institute (IGTP)
Jordi Barretina serves as the Director and CEO of Germans Trias i Pujol Research Institute (IGTP) since October 2020. Prior to this role, Jordi held the position of Director and CEO at Fundació Institut d'Investigació Biomèdica de Girona (IDIBGI) from February 2017 to October 2020. Jordi's experience also includes serving as Lab Head and Research Investigator at Novartis Institutes for BioMedical Research from September 2011 to January 2017, and as a Research Scientist in the Cancer Program at the Broad Institute of MIT and Harvard from June 2008 to September 2011. Earlier in their career, Jordi worked as a Postdoctoral Fellow in the Department of Medical Oncology at Dana-Farber Cancer Institute, Harvard Medical School from April 2005 to May 2008. Jordi holds a PhD in Biochemistry and Molecular Biology and a BSc in the same field, both obtained from Universitat Autònoma de Barcelona between 1996 and 2004.
This person is not in any teams
This person is not in any offices
Germans Trias i Pujol Research Institute (IGTP)
The Germans Trias i Pujol Research Institute (IGTP) is a public research centre located in Badalona. Its main objective is to increase scientific knowledge in order to transform it into solutions to improve the health and medical care of patients and the community. The Institute is associated with one of the major university hospitals in the Barcelona area, the Germans Trias i Pujol Hospital, and is part of the Can Ruti biomedical campus. IGTP is a CERCA centre and is also accredited as a centre of excellence by the Instituto de Salud Carlos III (ISCIII) and is in charge of coordinating the management and scientific strategy of the campus, working in close collaboration with the other centres. The mission of the IGTP is to be a centre of excellence that forms the backbone of a multidisciplinary and multi-institutional environment, allowing for cutting-edge translational research and innovation aimed at solving health challenges, from the prevention to the cure of diseases. Regarding its vision, IGTP aims to establish itself as a prestigious biomedical research centre that works to improve people's health and quality of life through maximum efficiency, sustainability, excellence, professional expertise, technological transfer, access to advanced technologies and cooperation, to ensure the greatest impact.